(Q34263746)

English

Intravitreal ranibizumab versus thermal laser photocoagulation in the treatment of extrafoveal classic choroidal neovascularization secondary to age-related macular degeneration

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Intravitreal ranibizumab versus thermal laser photocoagulation in the treatment of extrafoveal classic choroidal neovascularization secondary to age-related macular degeneration (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

light coagulation

1 reference

based on heuristic

inferred from title

neovascularization

1 reference

based on heuristic

inferred from title

author name string

Ioannis D Ladas

1

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Irini P Chatziralli

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Athanasios I Kotsolis

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Maria Douvali

4

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Ilias Georgalas

5

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Panagiotis G Theodossiadis

6

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Alexandros A Rouvas

7

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

publication date

9 May 2012

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Ophthalmologica

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

228

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

93-101

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Treatment of age-related macular degeneration: focus on ranibizumab

1 reference

https://api.crossref.org/works/10.1159%2F000337347

21 January 2018

Lesion morphology in age-related macular degeneration and its therapeutic significance

1 reference

https://api.crossref.org/works/10.1159%2F000337347

21 January 2018

Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With Verteporfin

1 reference

https://api.crossref.org/works/10.1159%2F000337347

21 January 2018

Photodynamic therapy with verteporfin for choroidal neovascularisations in clinical routine outside the TAP study. One- and two-year results including juxtafoveal and extrafoveal CNV.

1 reference

https://api.crossref.org/works/10.1159%2F000337347

21 January 2018

Verteporfin photodynamic therapy for extrafoveal choroidal neovascularisation secondary to age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1159%2F000337347

21 January 2018

Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-up

1 reference

https://api.crossref.org/works/10.1159%2F000337347

21 January 2018

Ranibizumab for neovascular age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1159%2F000337347

21 January 2018

Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

1 reference

https://api.crossref.org/works/10.1159%2F000337347

21 January 2018

Ranibizumab for treatment of choroidal neovascularization secondary to age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1159%2F000337347

21 January 2018

An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1159%2F000337347

21 January 2018

Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results

1 reference

https://api.crossref.org/works/10.1159%2F000337347

21 January 2018

Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1159%2F000337347

21 January 2018

A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study

1 reference

https://api.crossref.org/works/10.1159%2F000337347

21 January 2018

Use of digitized fluorescein angiogram system to guide laser treatment of diabetic macular edema: a new technique

1 reference

https://api.crossref.org/works/10.1159%2F000337347

21 January 2018

A 1-year retrospective review of ranibizumab for naive nonsubfoveal choroidal neovascularization secondary to age-related macular degeneration.

1 reference

https://api.crossref.org/works/10.1159%2F000337347

21 January 2018

Combined intravitreal anti-VEGF and verteporfin photodynamic therapy for juxtafoveal and extrafoveal choroidal neovascularization as an alternative to laser photocoagulation

1 reference

https://api.crossref.org/works/10.1159%2F000337347

21 January 2018

Current treatment of age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1159%2F000337347

21 January 2018

Identifiers

10.1159/000337347

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34263746&oldid=1544396495"